[Importance of dactinomycin in the current therapy of tumors].
D000328:Adult; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy; D002648:Child; D002986:Clinical Trials as Topic; D003609:Dactinomycin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004285:Dogs; D004351:Drug Resistance; D004407:Dysgerminoma / Q000188:drug therapy; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011247:Pregnancy; D012509:Sarcoma / Q000188:drug therapy; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D012983:Soft Tissue Neoplasms / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy; D014328:Trophoblastic Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D009396:Wilms Tumor / Q000188:drug therapy
D003609:Dactinomycin
Znachenie daktinomitsina v sovremennoĭ terapii opukholeĭ.